• Product NameMDL 29951
• Brief DescriptionInhibitors
• Purification99.49%
• Biological ActivityMDL-29951 is a novel glycine antagonist of NMDA receptor activation (Ki=0.14 mM, [3H]glycine binding) in vitro and in vivo.
• Target NameNMDAR antagonist
• CAS No. 130798-51-5
• Calculated MW 302.11
• Formulation C12H9Cl2NO4
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Other
  SMILES:OC(=O)CCC1=C(NC2=CC(Cl)=CC(Cl)=C12)C(O)=O
  Pathways:Neuroscience
  Receptor:NMDA receptor
  Boling pt:
  Melting pt:
  Solubility:DMSO: 10 mM
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Baron BM, et al. J Pharmacol Exp Ther. 1992 Sep;262(3):947-56.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting